-
-
-
-
-
-
-
Gilead (GILD) New Drug Filgotinib is Relatively Safe, But Black Box Still Likely - Baird
-
-
-
-
-
-
-
Baird Sees Gilead Sciences (GILD) Phase 3 Trial Data As Only A Modest Positive
-
-
-
-
-
-
-
Gilead Sciences (GILD): Multiple Nextgenvoya Study Results at IAS - Baird
-
-
-
-
-
-
-
Pharma Rumor Mill Working Overtime
-
-
-
-
-
-
-
Gilead Sciences to Present at the Baird 2015 Healthcare Conference on Wednesday, September 9
-
-
-
-
-
-
-
Streetinsider.com's Hot Lunchtime Reads 1/5: (JPM) (GILD) (MS) (ICPT) (PCYC)
-
-
-
-
-
-
-
Notable Analyst Rating Changes 8/15: (SHOO) (FANG) (MBI) Upgraded; (EXXI) (OVTI) (APO) Downgraded
-
22,803 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All